Validation of the Dutch translation of the Paris Arousal Disorders Severity Scale for NREM parasomnias in a one-year and one-month version.

We created a Dutch version of the Paris Arousal Disorders Severity Scale, which assesses non-rapid eye movement (NREM) parasomnia symptoms over the past year (PADSS-year). This questionnaire was previously validated in patients with sleep walking and/or sleep terrors ('SW/ST'). We validated the questionnaire in SW/ST patients, and in a broader population, including patients with confusional arousals, co-morbidities, and medication-users ('other NREM parasomnias'). Furthermore, we introduced a version covering the past month (PADSS-month), with the potential purpose of evaluating symptom evolution and treatment response.We compared PADSS scores among 54 SW/ST patients, 34 age-matched controls, and 23 patients with other NREM parasomnias. We evaluated discriminative capacity, internal consistency and construct validity. Furthermore, we assessed the test-retest reliability and treatment response of PADSS-month.Healthy controls scored significantly lower than both patient groups. We found an excellent diagnostic accuracy (AUC PADSS-year 0.990, PADSS-month 0.987) and an acceptable internal consistency. Exploratory factor analysis identified three components: 'behaviors outside the bed', 'behaviors in/around the bed', and 'violent behaviors', the former two factors reflecting the distinction between SW and ST. PADSS-month showed an acceptable test-retest reliability (0.75). Additionally, PADSS-month significantly decreased after pharmaceutical and/or behavioral treatment. This change was correlated with the clinical impression of the caregiver, implying that PADSS-month is sensitive to treatment effects.The Dutch PADSS questionnaire can be used as a screening tool in a broad population of NREM parasomnia patients, not only SW/ST. Furthermore, we validated a PADSS-month version, to assess the evolution of symptoms and treatment effect.